Table 5.
Gene mutations in CTCs from cancer patients.
| Sample number | Diagnosis | Stage | Pathological mutation | CTC counts (/4mL) | Tested mutation in CTCs | Result |
|---|---|---|---|---|---|---|
| 1 | NSCLC | IV | EGFR 19del | 11 | EGFR 19del | Positive |
| 2 | NSCLC | IV | EGFR 19del | 40 | EGFR 19del | Positive |
| 3 | NSCLC | IV | EGFR 19del | 7 | EGFR 19del | Positive |
| 4 | NSCLC | III | EGFR 19del | 3 | EGFR 19del | Positive |
| 5 | NSCLC | IV | EGFR 19del | 14 | EGFR 19del | Positive |
| 6 | PAAD | IV | KRAS G12D | 3 | KRAS G12D | Negative |
| 7 | PAAD | IV | KRAS G12D | 5 | KRAS G12D | Positive |
| 8 | PAAD | III | KRAS G12D | 25 | KRAS G12D | Positive |
| 9 | PAAD | IV | KRAS G12D | 6 | KRAS G12D | Positive |
| 10 | PAAD | IV | KRAS G12D | 10 | KRAS G12D | Positive |
| 11 | CRC | IV | BRAF V600E | 8 | BRAF V600E | Positive |
| 12 | CRC | III | BRAF V600E | 5 | BRAF V600E | Positive |
| 13 | CRC | IV | BRAF V600E | 10 | BRAF V600E | Positive |
| 14 | CRC | IV | BRAF V600E | 11 | BRAF V600E | Positive |
| 15 | CRC | IV | BRAF V600E | 6 | BRAF V600E | Positive |